AMGN Fair Price
$547.56
Overvalued by 0.3%
To display the fair price of a share, you need to be a member of Bulios Black.
My Notes
Začít psátFeed
Read More
Amgen and its MariTide programme: Is the stock drop worth the buying opportunity?
Amgen $AMGN recently disclosed the results of its obesity treatment candidate MariTide, which has completed Phase II clinical trials. Although the stock responded with a drop of more than 12%, it closed the day with only a 4.7% decline. The market viewed the results as less promising compared to...
Read more
Overall, the industry has a lot of potential right now. I'm probably most interested in $NVO so far and the stock is pretty down right now, so I'm thinking about buying.